ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Cullinan Therapeutics Inc

Cullinan Therapeutics Inc (CGEM)

13.45
0.36
(2.75%)
Closed November 30 4:00PM
13.45
0.00
(0.00%)
After Hours: 5:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
13.45
Bid
12.77
Ask
14.08
Volume
413,071
12.89 Day's Range 13.57
7.64 52 Week Range 30.1886
Market Cap
Previous Close
13.09
Open
13.41
Last Trade Time
Financial Volume
$ 5,529,948
VWAP
13.3874
Average Volume (3m)
537,435
Shares Outstanding
58,227,593
Dividend Yield
-
PE Ratio
-5.11
Earnings Per Share (EPS)
-2.63
Revenue
-
Net Profit
-153.16M

About Cullinan Therapeutics Inc

Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Cullinan Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CGEM. The last closing price for Cullinan Therapeutics was $13.09. Over the last year, Cullinan Therapeutics shares have traded in a share price range of $ 7.64 to $ 30.1886.

Cullinan Therapeutics currently has 58,227,593 shares outstanding. The market capitalization of Cullinan Therapeutics is $762.20 million. Cullinan Therapeutics has a price to earnings ratio (PE ratio) of -5.11.

CGEM Latest News

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024

Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global...

Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Global Phase 1 study of CLN-978 in systemic lupus erythematosus (SLE) cleared to initiate in U.S. and Australia; initial clinical data expected in Q4 2025 CLN-619 on-track for initial expansion...

Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference

CAMBRIDGE, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted...

Cullinan Therapeutics to Present Preclinical Data for CLN-978, a CD19-directed T Cell Engager, at ACR Convergence 2024

CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.189.6169519152412.2713.4512.149688112.67884164CS
4-2.26-14.385741565915.7117.503412.0458795314.61070288CS
12-4.39-24.607623318417.8418.619912.0453743516.16657493CS
26-8.87-39.740143369222.3224.7612.0464160117.63776891CS
524.8155.67129629638.6430.18867.6460502318.36425422CS
156-4.77-26.180021953918.2230.18867.337324915.28006233CS
260-28.55-67.97619047624259.857.334532018.0457846CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BSLKBolt Projects Holdings Inc
$ 0.71
(139.86%)
80.81M
PRZOParaZero Technologies Ltd
$ 1.24
(94.14%)
205.02M
AIEVThunder Power Holdings Inc
$ 0.47
(87.25%)
122.71M
PASGPassage Bio Inc
$ 1.13
(69.52%)
15.44M
EPOWSunrise New Energy Company Ltd
$ 1.06
(45.21%)
314.9k
APLTApplied Therapeutics Inc
$ 2.03
(-76.31%)
42.74M
TGLTreasure Global Inc
$ 0.2944
(-29.08%)
1.83M
PROCProcaps Group SA
$ 1.51
(-27.75%)
98.71k
SHOTWSafety Shot Inc
$ 0.104
(-20.00%)
1.43k
MONDMondee Holdings Inc
$ 0.7102
(-19.59%)
297.61k
PRZOParaZero Technologies Ltd
$ 1.24
(94.14%)
205.02M
NVDANVIDIA Corporation
$ 138.25
(2.15%)
141.86M
AIEVThunder Power Holdings Inc
$ 0.47
(87.25%)
122.71M
RGTIRigetti Computing Inc
$ 3.05
(27.08%)
116.98M
MARAMARA Holdings Inc
$ 27.42
(1.86%)
89.54M

Your Recent History

Delayed Upgrade Clock